HK48890A - Substituted spiro pyridine derivatives,pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions - Google Patents

Substituted spiro pyridine derivatives,pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions

Info

Publication number
HK48890A
HK48890A HK488/90A HK48890A HK48890A HK 48890 A HK48890 A HK 48890A HK 488/90 A HK488/90 A HK 488/90A HK 48890 A HK48890 A HK 48890A HK 48890 A HK48890 A HK 48890A
Authority
HK
Hong Kong
Prior art keywords
compounds
processes
preparation
pyridine derivatives
substituted spiro
Prior art date
Application number
HK488/90A
Other languages
English (en)
Inventor
David John Blythin
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/561,416 external-priority patent/US4652564A/en
Priority claimed from US06/641,076 external-priority patent/US4632923A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK48890A publication Critical patent/HK48890A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
HK488/90A 1983-12-14 1990-06-21 Substituted spiro pyridine derivatives,pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions HK48890A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/561,416 US4652564A (en) 1983-12-14 1983-12-14 Substituted spiro pyridine derivatives as anti-allergy and antiinflammatory agents
US06/641,076 US4632923A (en) 1984-08-15 1984-08-15 Substituted hetero spiro pyridine derivatives as anti-allergy and anti-inflammatory agents

Publications (1)

Publication Number Publication Date
HK48890A true HK48890A (en) 1990-06-29

Family

ID=27072640

Family Applications (1)

Application Number Title Priority Date Filing Date
HK488/90A HK48890A (en) 1983-12-14 1990-06-21 Substituted spiro pyridine derivatives,pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions

Country Status (18)

Country Link
EP (1) EP0144996B1 (de)
JP (1) JPH066586B2 (de)
KR (1) KR900004832B1 (de)
AU (1) AU574749B2 (de)
CA (1) CA1252786A (de)
DE (1) DE3481418D1 (de)
DK (1) DK169721B1 (de)
FI (1) FI79539C (de)
GB (1) GB2153348B (de)
GR (1) GR82463B (de)
HK (1) HK48890A (de)
HU (1) HU193913B (de)
IL (1) IL73823A (de)
MY (1) MY100602A (de)
NO (1) NO163896C (de)
NZ (1) NZ210551A (de)
OA (1) OA07899A (de)
PT (1) PT79672A (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3669656D1 (de) * 1985-06-18 1990-04-26 Schering Corp Azanaphthalene enthaltende arzneimittelzusammensetzungen.
DE3786036T2 (de) * 1986-04-11 1993-09-09 Schering Corp Arylsubstituierte naphthyridin- und pyridopyrazin-derivate.
US5045542A (en) * 1986-10-20 1991-09-03 Schering Corporation Immune suppression method employing aryl-substituted naphthyridine and pyridopyrazine derivatives
CA1309658C (en) * 1986-12-05 1992-11-03 David J. Blythin Pharmaceutical compositions for treatment of hyperproliferate skin disease
US5350755A (en) * 1986-12-05 1994-09-27 Schering Corporation Compounds and methods for treating hyperproliferative skin disease
EP1202994B1 (de) 1999-07-21 2004-04-14 AstraZeneca AB Verbindungen
US7592457B2 (en) * 2004-10-20 2009-09-22 Korea Research Institute Of Chemical Technology 3-aryl-3-methyl-quinoline-2, 4-diones, preparation method thereof, and pharmaceutical composition containing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB855022A (en) * 1957-08-06 1960-11-30 Geigy Ag J R Improvements in and relating to carbostyril derivatives
JPS5089376A (de) * 1973-12-19 1975-07-17
US4215216A (en) * 1979-04-18 1980-07-29 American Home Products Corporation 7,8-Dihydro-2,5,8-trisubstituted-7-oxo-pyrido[2,3-d]pyrimidine-6-carboxylic acid derivatives
EP0092786B1 (de) * 1982-04-26 1987-01-07 Schering Corporation 1,8-Naphthyridine- und 1,5,8-Azanaphthyridine-Derivate

Also Published As

Publication number Publication date
DE3481418D1 (de) 1990-04-05
OA07899A (fr) 1986-11-20
DK597184D0 (da) 1984-12-13
DK597184A (da) 1985-06-15
NO163896B (no) 1990-04-30
NO845016L (no) 1985-06-17
FI844919A0 (fi) 1984-12-13
NO163896C (no) 1990-08-08
FI79539B (fi) 1989-09-29
JPH066586B2 (ja) 1994-01-26
KR850004487A (ko) 1985-07-15
EP0144996B1 (de) 1990-02-28
EP0144996A3 (en) 1986-06-11
MY100602A (en) 1990-12-15
EP0144996A2 (de) 1985-06-19
PT79672A (en) 1985-01-01
IL73823A (en) 1988-03-31
CA1252786A (en) 1989-04-18
NZ210551A (en) 1988-05-30
GB8431542D0 (en) 1985-01-23
FI79539C (fi) 1990-01-10
GB2153348B (en) 1987-08-12
HU193913B (en) 1987-12-28
GB2153348A (en) 1985-08-21
DK169721B1 (da) 1995-01-23
KR900004832B1 (ko) 1990-07-07
HUT36477A (en) 1985-09-30
IL73823A0 (en) 1985-03-31
GR82463B (en) 1985-04-16
FI844919L (fi) 1985-06-15
AU3662484A (en) 1985-06-20
AU574749B2 (en) 1988-07-14
JPS60156689A (ja) 1985-08-16

Similar Documents

Publication Publication Date Title
IL62082A (en) Beta-lactam derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
DE3366393D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
GB2071095B (en) Heterocyclic compounds processes for their preparation and pharmaceutical compositions containing them
IL70966A0 (en) Imidazoline derivatives and related compounds,their preparation and pharmaceutical compositions containing them
ZA849499B (en) Indole derivatives,processes for their preparation and pharmaceutical compositions containing them
IL72752A0 (en) (substituted)phenyl-aliphatic isoxazole derivatives,their preparation and pharmaceutical compositions containing them
DE3264121D1 (en) Ergoline derivatives, processes for their preparation and pharmaceutical compositions containing them
DE3475709D1 (en) Ergoline derivatives, processes for their preparation and pharmaceutical compositions containing same
IL72471A0 (en) Pharmaceutical compositions containing phenylquinoline-carboxylic acids and derivatives thereof,certain such novel compounds and their preparation
PT81502A (en) Process for the preparation of cholecalciferol derivatives and of pharmaceutical compositions containing the same
ZA849734B (en) Substituted spiro pyridine derivatives pharmaceutical compositions containing them and process for the preparation of such compounds and compositions
IL73823A0 (en) Substituted spiro pyridine derivatives,pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions
PT76870B (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
IL70508A (en) Pharmaceutical compositions containing aralkyltriazole derivatives,some such novel compounds and their preparation
PT79199A (en) Process for preparing 3-indolecarboxamide derivatives and of pharmaceutical compositions containing the same
ZA839437B (en) Substituted azabicycloalkanes,the use thereof,pharmaceutical compositions containing them,and processes for the preparation of these compounds
DE3380695D1 (en) Isocarbostyril derivatives, processes for their preparation and pharmaceutical compositions containing them
DE3166538D1 (en) Novel quinoline derivatives, pharmaceutical compositions containing such compounds, and method for the preparation of these compounds
ZA841781B (en) Penim compounds,methods for their preparation and pharmaceutical compositions containing them
IL72831A (en) (5r,6s)-2-aminomethyl-penem compounds,their preparation and pharmaceutical compositions containing them
EP0035820A3 (en) Novel quinoline derivatives, pharmaceutical compositions containing such compounds, and method for the preparation of these compounds
IL71078A (en) Pharmaceutical compositions comprising n-aminoethyl-benzamide derivatives,certain such novel compounds and their preparation
IL70084A0 (en) Pyridine derivatives,their preparation and pharmaceutical compositions containing them
IL100301A0 (en) Pyridyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them
IL73586A0 (en) Pyrimidoisoquinoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)